Terms: = Gastric cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Prognosis
56 results:
1. TUMOR MARKERS EXPRESSION LEVELS IN gastric cancer PATIENT'S PERIPHERAL BLOOD BY RT-PCR ASSESSMENT.
Kawakami GDS; Pereira MA; Kubrusly MS; Carrasco AGM; Ramos MFKP; Ribeiro Júnior U
Arq Bras Cir Dig; 2024; 36():e1789. PubMed ID: 38324850
[TBL] [Abstract] [Full Text] [Related]
2. New developments and standard of care in the management of advanced gastric cancer.
Depotte L; Palle J; Rasola C; Broudin C; Afrăsânie VA; Mariani A; Zaanan A
Clin Res Hepatol Gastroenterol; 2024 Jan; 48(1):102245. PubMed ID: 37952913
[TBL] [Abstract] [Full Text] [Related]
3. A Model for gastric cancer Risk Prediction Based on
Nguyen NT; Dang NDT; Vu QV; Dang AK; Ta TV
In Vivo; 2023; 37(5):2347-2356. PubMed ID: 37652501
[TBL] [Abstract] [Full Text] [Related]
4. Rab31 promotes metastasis and cisplatin resistance in stomach adenocarcinoma through Twist1-mediated EMT.
Chen K; Xu J; Tong YL; Yan JF; Pan Y; Wang WJ; Zheng L; Zheng XX; Hu C; Hu X; Shen X; Chen W
Cell Death Dis; 2023 Feb; 14(2):115. PubMed ID: 36781842
[TBL] [Abstract] [Full Text] [Related]
5. [Immunotherapy in advanced gastric cancer].
Zaanan A
Bull Cancer; 2022 Oct; 109(10):1066-1072. PubMed ID: 36055806
[TBL] [Abstract] [Full Text] [Related]
6. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
[TBL] [Abstract] [Full Text] [Related]
7. Predictive model for risk of gastric cancer using genetic variants from genome-wide association studies and high-evidence meta-analysis.
Qiu L; Qu X; He J; Cheng L; Zhang R; Sun M; Yang Y; Wang J; Wang M; Zhu X; Guo W
Cancer Med; 2020 Oct; 9(19):7310-7316. PubMed ID: 32777176
[TBL] [Abstract] [Full Text] [Related]
8. Identification of novel biomarkers, MUC5AC, muc1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract] [Full Text] [Related]
9. Association of high-evidence gastric cancer susceptibility loci and somatic gene expression levels with survival.
Sung H; Hu N; Yang HH; Giffen CA; Zhu B; Song L; Su H; Wang C; Parisi DM; Goldstein AM; Taylor PR; Hyland PL
Carcinogenesis; 2017 Oct; 38(11):1119-1128. PubMed ID: 29028942
[TBL] [Abstract] [Full Text] [Related]
10. muc1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.
Betge J; Schneider NI; Harbaum L; Pollheimer MJ; Lindtner RA; Kornprat P; Ebert MP; Langner C
Virchows Arch; 2016 Sep; 469(3):255-65. PubMed ID: 27298226
[TBL] [Abstract] [Full Text] [Related]
11. muc1 Immunohistochemical Expression as a Prognostic Factor in gastric cancer: Meta-Analysis.
Wang XT; Kong FB; Mai W; Li L; Pang LM
Dis Markers; 2016; 2016():9421571. PubMed ID: 27190429
[TBL] [Abstract] [Full Text] [Related]
12. Phagocytosis (cannibalism) of apoptotic neutrophils by tumor cells in gastric micropapillary carcinomas.
Barresi V; Branca G; Ieni A; Rigoli L; Tuccari G; Caruso RA
World J Gastroenterol; 2015 May; 21(18):5548-54. PubMed ID: 25987778
[TBL] [Abstract] [Full Text] [Related]
13. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Distler M; Kersting S; Niedergethmann M; Aust DE; Franz M; Rückert F; Ehehalt F; Pilarsky C; Post S; Saeger HD; Grützmann R
Ann Surg; 2013 Aug; 258(2):324-30. PubMed ID: 23532107
[TBL] [Abstract] [Full Text] [Related]
14. Immunohistochemical analysis of invasive micropapillary carcinoma pattern in four cases of gastric cancer.
Ohtsuki Y; Kuroda N; Yunoki S; Murakami S; Mizukami Y; Okada Y; Iguchi M; Lee GH; Furihata M
Med Mol Morphol; 2013 Jun; 46(2):114-21. PubMed ID: 23471758
[TBL] [Abstract] [Full Text] [Related]
15. Preoperative histological subtype classification of intraductal papillary mucinous neoplasms (IPMN) by pancreatic juice cytology with MUC stain.
Hara T; Ikebe D; Odaka A; Sudo K; Nakamura K; Yamamoto H; Itami M; Hirata T; Kashimura J; Yamaguchi T
Ann Surg; 2013 Jun; 257(6):1103-11. PubMed ID: 23364699
[TBL] [Abstract] [Full Text] [Related]
16. The contribution of cell phenotype to the behavior of gastric cancer.
Solcia E; Klersy C; Vanoli A; Grillo F; Manca R; Tava F; Luinetti O; Fiocca R
Gastric Cancer; 2013 Oct; 16(4):462-71. PubMed ID: 23329390
[TBL] [Abstract] [Full Text] [Related]
17. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
[TBL] [Abstract] [Full Text] [Related]
18. A novel anti-muc1 antibody against the muc1 cytoplasmic tail domain: use in sensitive identification of poorly differentiated cells in adenocarcinoma of the stomach.
Yonezawa S; Kitajima S; Higashi M; Osako M; Horinouchi M; Yokoyama S; Kitamoto S; Yamada N; Tamura Y; Shimizu T; Tabata M; Goto M
Gastric Cancer; 2012 Oct; 15(4):370-81. PubMed ID: 22237656
[TBL] [Abstract] [Full Text] [Related]
19. Advisability of palliative resections in incurable advanced gastric cancer.
Al-Amawi T; Swider-Al-Amawi M; Halczak M; Wojtasik P; Kładny J
Pol Przegl Chir; 2011 Aug; 83(8):449-56. PubMed ID: 22166719
[TBL] [Abstract] [Full Text] [Related]
20. Tumor-infiltrating neutrophils in pancreatic neoplasia.
Reid MD; Basturk O; Thirabanjasak D; Hruban RH; Klimstra DS; Bagci P; Altinel D; Adsay V
Mod Pathol; 2011 Dec; 24(12):1612-9. PubMed ID: 21822201
[TBL] [Abstract] [Full Text] [Related]
[Next]
